SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biotech Valuation
CRSP 57.03-0.6%1:17 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Biomaven who started this subject11/3/2001 9:32:39 PM
From: blackmerlin  Read Replies (1) of 52153
 
Several select biotech stocks are doing well (see biobiznet.com). On the site, their were seven winning stocks (+2.18 to +75.53%) bought between May 1 and Nov. 2, 2001. However there were also six that declined. It looks like some of the winners are still going up and still might be a possibility that some of the losses might pick up. But of course, this depends on the climate that surrounds the biotechnology business and individual companies and the ability of the companies to take advantage of: the capital markets & government resources, intellectual property issues, partnering, experienced investigators & managers, clinical trials progression, and access to manufacturing facilities & resources, etc.

Regards,
Jake Blackmerlin
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext